- Home
- BRKRP vs OCCIN Comparison
BRKRP vs OCCIN Comparison
Compare BRKRP & OCCIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRKRP | OCCIN |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 11396 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BRKRP | OCCIN |
|---|---|---|
| Price | $358.00 | $24.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | N/A |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | N/A |
| 52 Week High | N/A | N/A |
Technical Indicators
Market Signals| Indicator | BRKRP | OCCIN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.51 |
| Support Level | N/A | $24.43 |
| Resistance Level | N/A | $24.62 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 53.85 |
Price Performance
Historical ComparisonAbout BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About OCCIN OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.